Skip to content

Calidi Biotherapeutics via Edoc Acquisition (ADOC) deck

Calidi Biotherapeutics is a clinical-stage biotechnology company that is pioneering the development of cell-based delivery of oncolytic viruses.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest